🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David J. DeGraff

Pennsylvania State University

ORCID: 0000-0002-7154-7594

Also affiliated with Penn State Milton S. Hershey Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes”.

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes

Nature Reviews Urology(2020)10.1038/s41585-020-0304-1
N/A
0.794DataRank · unranked
198 citations

Hikmat Al‐Ahmadie, Bishoy M. Faltas, John A. Taylor, Thomas W. Flaig, David J. DeGraff +5 more

Pan‐cancer analysis of prognostic metastatic phenotypes

International Journal of Cancer(2021)10.1002/ijc.33744
N/A
0DataRank · unranked
36 citations

Xi Wang, Sara M. Garrett, Eric J. Lehrer, Christine Lin, David J. DeGraff +9 more

EA8185: Phase II study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), ECOG-ACRIN/nrg collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps500
N/A
0DataRank · unranked
4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

AUTS2 controls neuronal lineage choice through a novel PRC1-independent complex and BMP inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.29.450402
N/A
0DataRank · unranked
3 citations

Qiang Wang, Weili Miao, Trevor Wolf, Jessenia Chavez, Emily Giddings +6 more

Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis

Nature Communications(2021)10.1038/s41467-021-22327-5
N/A
0DataRank · unranked
72 citations

Yan Liu, Chao Yang, Diane M. Simeone, Tung‐Tien Sun, David J. DeGraff +4 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node-positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4617
N/A
0DataRank · unranked
4 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE), an ECOG-ACRIN/NRG collaboration.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps594
N/A
0DataRank · unranked
0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more

Microbial Product Cocktails for Personalized Cancer Immunotherapy

Nature Communications(2025)10.1038/s41467-025-66238-1
N/A
0DataRank · unranked
3 citations

Sijia Yang, Kathleen E. Mach, Guoli Chen, David J. DeGraff, Joseph C. Liao +2 more

EA8185: Phase 2 study of bladder-sparing chemoradiation (chemoRT) with durvalumab in clinical stage III, node positive urothelial carcinoma (INSPIRE)—An ECOG-ACRIN and NRG Collaboration.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4590
N/A
0DataRank · unranked
0 citations

Se Eun Kim, Abhishek A. Solanki, David T. Miyamoto, David J. DeGraff, Jennifer Wei Zou +8 more